Clinical Trial: Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129579

Registration Time: 2026/08/06

Type: Interventional study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337015

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma (China)